Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neutropenia 5Breast Neoplasms 5Febrile Neutropenia 3Wilms Tumor 1Uterine Cervical Neoplasms 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Malignant Solid Tumors 1Lymphoma 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breastcancer 1Breast Cancer Female 1

Interventions

pegylated granulocyte colony-stimulating factor 1Trastuzumab 1Omacor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breastcancer × pegylated granulocyte colony-stimulating factor × Clear all
NCT02944604 2019-01-18

The Efficacy and Safety of PEG-rhG-CSF(Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy

Peking University

Phase 4 Completed
240 enrolled
Breast

Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡